SCHEMBL1660117

SCHEMBL1660117

CCc1cc(-c2ccc(C(=O)O)o2)cc(C(F)(F)F)c1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
RXRA P19793 3/20 0.45
RXRB P28702 3/20 0.45
RXRG P48443 3/20 0.45
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
RPA1 P27694 1/20 0.44
SLC9A1 P19634 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1658932 0.87 NR4A1 (0.54) NR4A1NR4A2NR4A3CYP1A2CYP2C19
SCHEMBL1991640 0.78 HDAC4 (0.56) CYP1A2CYP2C19RXRARXRBRXRG
SCHEMBL12521317 0.77 NR4A1 (0.45) NR4A1NR4A2NR4A3CYP1A2CYP2C19
SCHEMBL1222870 0.77 SLC9A1 (0.67) NR4A1NR4A2NR4A3CYP1A2CYP2C19
SCHEMBL12563595 0.77 CYP1A2 (0.51) CYP1A2CYP2C19RXRARXRBRXRG
SCHEMBL2868769 0.76 NOTUM (0.45) NR4A1NR4A2NR4A3CYP1A2CYP2C19
SCHEMBL3744237 0.76 ALDH1A1 (0.64) NR4A1NR4A2NR4A3ALDH1A1HPGD
SCHEMBL9613179 0.76 ALDH1A1 (0.68) NR4A1NR4A2NR4A3ALDH1A1HPGD
SCHEMBL1410412 0.75 RXRA (0.44) NR4A1NR4A2NR4A3CYP1A2CYP2C19
SCHEMBL12563582 0.75 CYP1A2 (0.51) CYP1A2CYP2C19ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP claimed
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed